Quarterly report pursuant to Section 13 or 15(d)

Schedule of Accounts Payable and Accrued Liabilities (Details)

v3.22.2.2
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Oct. 31, 2022
Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Research and development costs $ 3,402,401 $ 3,210,627
Professional services fees 1,319,890 877,411
Other 80,165 120,184
Total $ 4,802,456 $ 4,208,222